Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype

INTRODUCTION: Estrogen receptor (ER) and progesterone receptor (PR) testing are performed in the evaluation of breast cancer. While the clinical utility of ER as a predictive biomarker to identify patients likely to benefit from hormonal therapy is well-established, the added value of PR is less wel...

詳細記述

保存先:
書誌詳細
主要な著者: Hefti, Marco M, Hu, Rong, Knoblauch, Nicholas W, Collins, Laura C, Haibe-Kains, Benjamin, Tamimi, Rulla M, Beck, Andrew H
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978610/
https://ncbi.nlm.nih.gov/pubmed/23971947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3462
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料